Q9NWQ8 (PAG1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 75.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Alternative name(s): Csk-binding protein Transmembrane adapter protein PAG Transmembrane phosphoprotein Cbp | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 432 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Negatively regulates TCR (T-cell antigen receptor)-mediated signaling in T-cells and FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Promotes CSK activation and recruitment to lipid rafts, which results in LCK inhibition. Inhibits immunological synapse formation by preventing dynamic arrangement of lipid raft proteins. May be involved in cell adhesion signaling. Ref.1 |
| Subunit structure | Interacts with FYN. When phosphorylated, interacts with CSK. Interacts with SLC9A3R1/EBP50. In resting T-cells, part of a PAG1-SLC9A3R1-MSN complex which is disrupted upon TCR activation. Interacts with LYN on plasma membrane lipid rafts. Identified in a complex with LYN and STAT3. Ref.1 Ref.5 Ref.9 |
| Subcellular location | Cell membrane; Single-pass type III membrane protein. Note: Present in lipid rafts. Ref.1 Ref.9 |
| Tissue specificity | Ubiquitously expressed. Present in germinal center B-cells, plasma cells, T-cells, monocytes and platelets (at protein level). Ref.1 Ref.6 |
| Post-translational modification | Palmitoylated. Ref.1 Phosphorylated by FYN on Tyr-317 in resting T-cells; which promotes interaction with CSK. Dephosphorylated by PTPRC/CD45 upon TCR activation; which leads to CSK dissociation. May also be dephosphorylated by PTPN11. Hyperphosphorylated in mast cells upon FCER1 activation. Phosphorylated by LYN. Ref.1 Ref.7 Ref.8 Ref.9 Ref.10 Ref.11 |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 432 | 432 | Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 | PRO_0000083338 | |||||
Regions | |||||||||
| Topological domain | 1 – 16 | 16 | Extracellular Potential | ||||||
| Transmembrane | 17 – 37 | 21 | Helical; Signal-anchor for type III membrane protein; Potential | ||||||
| Topological domain | 38 – 432 | 395 | Cytoplasmic Potential | ||||||
| Region | 317 – 320 | 4 | Interaction with CSK | ||||||
| Region | 430 – 432 | 3 | Interaction with SLC9A3R1 | ||||||
Amino acid modifications | |||||||||
| Modified residue | 163 | 1 | Phosphotyrosine Ref.11 | ||||||
| Modified residue | 181 | 1 | Phosphotyrosine By similarity | ||||||
| Modified residue | 227 | 1 | Phosphotyrosine Ref.10 Ref.11 | ||||||
| Modified residue | 317 | 1 | Phosphotyrosine; by FYN and LYN Ref.1 Ref.7 Ref.9 Ref.11 | ||||||
| Modified residue | 341 | 1 | Phosphotyrosine Ref.7 Ref.10 | ||||||
| Modified residue | 359 | 1 | Phosphotyrosine Ref.7 Ref.11 | ||||||
| Modified residue | 380 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 387 | 1 | Phosphotyrosine Ref.11 | ||||||
| Modified residue | 417 | 1 | Phosphotyrosine Ref.7 Ref.8 Ref.11 | ||||||
| Lipidation | 37 | 1 | S-palmitoyl cysteine Probable | ||||||
| Lipidation | 40 | 1 | S-palmitoyl cysteine Probable | ||||||
Experimental info | |||||||||
| Mutagenesis | 105 | 1 | Y → F: No effect on interaction with FYN or CSK. Ref.1 | ||||||
| Mutagenesis | 163 | 1 | Y → F: No effect on interaction with FYN or CSK. Ref.1 | ||||||
| Mutagenesis | 181 | 1 | Y → F: No effect on interaction with FYN or CSK. Ref.1 | ||||||
| Mutagenesis | 227 | 1 | Y → F: No effect on interaction with FYN or CSK. Ref.1 | ||||||
| Mutagenesis | 299 | 1 | Y → F: No effect on interaction with FYN or CSK. Ref.1 | ||||||
| Mutagenesis | 317 | 1 | Y → F: No effect on interaction with FYN. Abolishes interaction with CSK. Ref.1 | ||||||
| Mutagenesis | 341 | 1 | Y → F: No effect on interaction with FYN or CSK. Ref.1 | ||||||
| Mutagenesis | 359 | 1 | Y → F: No effect on interaction with FYN or CSK. Ref.1 | ||||||
| Mutagenesis | 387 | 1 | Y → F: No effect on interaction with FYN or CSK. Ref.1 | ||||||
| Mutagenesis | 417 | 1 | Y → F: No effect on interaction with FYN or CSK. Ref.1 | ||||||
| Sequence conflict | 4 | 1 | A → V in AAH90931. Ref.4 | ||||||
| Sequence conflict | 36 | 1 | L → P in BAA91321. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation." Brdicka T., Pavlistova D., Bruyns E., Leo A., Korinek V., Angelisova P., Scherer J., Shevchenko A., Shevchenko A., Hilgert I., Cerny J., Drbal K., Kuramitsu Y., Horejsi V., Schraven B. J. Exp. Med. 191:1591-1604(2000) [PubMed: 10790433] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 264-274, IDENTIFICATION BY MASS SPECTROMETRY, PHOSPHORYLATION AT TYR-317, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, PALMITOYLATION AT CYS-37 AND CYS-40, MUTAGENESIS OF TYR-105; TYR-163; TYR-181; TYR-227; TYR-299; TYR-317; TYR-341; TYR-359; TYR-387 AND TYR-417, INTERACTION WITH FYN AND CSK, FUNCTION. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain and Ileal mucosa. |
| [3] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain and Lymph. |
| [5] | "Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton." Brdickova N., Brdicka T., Andera L., Spicka J., Angelisova P., Milgram S.L., Horejsi V. FEBS Lett. 507:133-136(2001) [PubMed: 11684085] [Abstract] Cited for: INTERACTION WITH SLC9A3R1. |
| [6] | "Transmembrane adaptor molecules: a new category of lymphoid-cell markers." Tedoldi S., Paterson J.C., Hansmann M.-L., Natkunam Y., Rudiger T., Angelisova P., Du M.Q., Roberton H., Roncador G., Sanchez L., Pozzobon M., Masir N., Barry R., Pileri S., Mason D.Y., Marafioti T., Horejsi V. Blood 107:213-221(2006) [PubMed: 16160011] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [7] | "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer." Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. Comb M.J.Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-317; TYR-341; TYR-359 AND TYR-417, MASS SPECTROMETRY. Tissue: Lung carcinoma. |
| [8] | "Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks." Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M. Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007) [PubMed: 17389395] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-417, MASS SPECTROMETRY. Tissue: Mammary epithelium. |
| [9] | "Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts." Tauzin S., Ding H., Khatib K., Ahmad I., Burdevet D., van Echten-Deckert G., Lindquist J.A., Schraven B., Din N.U., Borisch B., Hoessli D.C. Blood 111:2310-2320(2008) [PubMed: 18070987] [Abstract] Cited for: PHOSPHORYLATION AT TYR-317, INTERACTION WITH LYN AND STAT3, SUBCELLULAR LOCATION. |
| [10] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-227 AND TYR-341, MASS SPECTROMETRY. |
| [11] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-163; TYR-227; TYR-317; TYR-359; TYR-387 AND TYR-417, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF240634 mRNA. Translation: AAF67343.1. AK000680 mRNA. Translation: BAA91321.1. AK289818 mRNA. Translation: BAF82507.1. CH471068 Genomic DNA. Translation: EAW87086.1. BC090931 mRNA. Translation: AAH90931.1. BC112159 mRNA. Translation: AAI12160.1. |
| IPI | IPI00020464. |
| RefSeq | NP_060910.3. NM_018440.3. |
| UniGene | Hs.266175. |
3D structure databases | |
| ProteinModelPortal | Q9NWQ8. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9NWQ8. 1 interaction. |
| MINT | MINT-220429. |
| STRING | Q9NWQ8. |
PTM databases | |
| PhosphoSite | Q9NWQ8. |
Polymorphism databases | |
| DMDM | 84029384. |
Proteomic databases | |
| PeptideAtlas | Q9NWQ8. |
| PRIDE | Q9NWQ8. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000220597; ENSP00000220597; ENSG00000076641. |
| GeneID | 55824. |
| KEGG | hsa:55824. |
| UCSC | uc003ybz.1. human. |
Organism-specific databases | |
| CTD | 55824. |
| GeneCards | GC08M081880. |
| H-InvDB | HIX0007615. |
| HGNC | HGNC:30043. PAG1. |
| HPA | HPA001632. |
| MIM | 605767. gene. |
| neXtProt | NX_Q9NWQ8. |
| PharmGKB | PA142671201. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG11418. |
| GeneTree | ENSGT00390000002061. |
| HOGENOM | HBG279366. |
| HOVERGEN | HBG055052. |
| InParanoid | Q9NWQ8. |
| OMA | VNKPGQS. |
| OrthoDB | EOG4CRM0T. |
| PhylomeDB | Q9NWQ8. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | bcr_5pathway. BCR signaling pathway. tcrpathway. TCR signaling in naive CD4+ T cells. cd8tcrpathway. TCR signaling in naive CD8+ T cells. |
| Reactome | REACT_111102. Signal Transduction. REACT_6900. Immune System. |
Gene expression databases | |
| ArrayExpress | Q9NWQ8. |
| Bgee | Q9NWQ8. |
| CleanEx | HS_PAG1. |
| Genevestigator | Q9NWQ8. |
| GermOnline | ENSG00000076641. Homo sapiens. |
Family and domain databases | |
| ProtoNet | Search... |
Other | |
| NextBio | 61018. |
| SOURCE | Search... |
Entry information
| Entry name | PAG1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NWQ8 Secondary accession number(s): A8K1A3 Q9NYK0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |

Clusters with